Cohignac V

Medical Affairs, Janssen-Cilag, Issy-les-Moulineaux, France.

2 papers · ORCID

ArticleKetamine

Effectiveness and factors associated with esketamine response during the 4-week induction period for treatment-resistant depression: post-hoc analysis of the real-world ESKALE study.

Samalin L, Rothärmel M, Mekaoui L +6

Europe PMC2026
ArticleKetamine

Use of Esketamine Nasal Spray in Patients with Treatment-Resistant Depression in Routine Practice: A Real-World French Study.

Samalin L, Mekaoui L, Rothärmel M +5

Europe PMC2024